{"id":"W2030987445","doi":"10.1186/s12931-014-0123-0","title":"Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study","year":2014,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Takeda Pharmaceuticals International; GlaxoSmithKline; Actavis; Almirall; Ironwood Pharmaceuticals, Incorporated; Forest Research Institute; Sunovion; Sanofi; Forest Laboratories; Mylan; AstraZeneca; Pfizer","keywords":"Formoterol; Medicine; Formoterol Fumarate; COPD; Fixed-dose combination; Dry-powder inhaler; Tolerability; Placebo; Muscarinic antagonist; Inhaler; Anesthesia; Adverse effect; Internal medicine; Asthma; Inhalation; Antagonist; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01476416,0.0003341276,0.001703108,0.0006920478,0.0004834181,0.00006005054,0.0005933897,0.0001409829,0.000348874],"category_scores_gemma":[0.005337446,0.0002205536,0.0003310537,0.0008383979,0.001993433,0.0001454836,0.0006008066,0.001064182,0.00004902187],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003468353,"about_ca_system_score_gemma":0.0008009162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001603363,"about_ca_topic_score_gemma":0.00003442669,"domain_scores_codex":[0.9890627,0.005560192,0.001346357,0.0006668489,0.002547524,0.0008163989],"domain_scores_gemma":[0.9886852,0.007806584,0.0003224993,0.001374224,0.001346713,0.0004647814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9383091,0.01073307,0.01266865,0.001297327,0.001866955,0.00006122371,0.001704334,0.00007814795,0.009535876,0.003587138,0.00279313,0.01736506],"study_design_scores_gemma":[0.8768501,0.003092811,0.1065657,0.0003051384,0.0003903276,0.00001102528,0.002027524,0.004486369,0.002160267,0.0003792883,0.003473653,0.0002577796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780492,0.002240385,0.00007094855,0.000967046,0.0001155922,0.01293476,0.00004325238,0.00003412058,0.005544744],"genre_scores_gemma":[0.9972779,0.0001608332,0.00002583457,0.00008853794,0.000140574,0.0007935925,0.00001472774,0.00005564544,0.001442343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0938971,"threshold_uncertainty_score":0.8993915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05672925672933922,"score_gpt":0.3655891636817695,"score_spread":0.3088599069524303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}